Everardus Kruyf
- Naam
- Dr. E.J.F.M. Kruyf
- Telefoon
- +31 71 526 2267
- e.j.f.m.kruyf@umail.leidenuniv.nl
- Faculteit Geneeskunde
- Divisie 4
- Hematologie
- Kruijf, E.J.F.M. de; Zuijderduijn, R.; Stip, M.C.; Fibbe, W.E. & Pel, M. van (2018), Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice, Experimental Hematology.
- Kruijf, E.J.F.M. de; Alkemade, G.M.; Os, R. van; Fibbe, W.E. & Pel, M. van (2014), Peripheral blood hematopoietic stem and progenitor cell frequency is unchanged in patients with alpha-1-antitrypsin deficiency, International Journal of Hematology 99(6): 714-720.
- Kruijf, E.J.F.M. de; Hengel, I. van; Perez-Galarza, J.M.; Fibbe, W.E. & Pel, M. van (2013), Mesenchymal Stromal Cells Enhance G-CSF-Induced Mobilization Of Hematopoietic Stem- and Progenitor Cells, Blood 122(21).
- Nijhof, I.S.; Zweegman, S.; Levin, M.D.; Koene, H.R.; Beeker, A.; Bloem, A.C.; Bos, G.M.J.; Faber, L.M.; Klein, S.K.; Kruijf, E.J.F.M. de; Spek, E. van der; Wittebol, S.; Velzen, J.F. van; Kessel, B. van; Mutis, T.; Sonneveld, P.; Lokhorst, H. & Donk, N.W.C.J. van de (2013), Phase 1/2 Trial Of Lenalidomide In Combination With Cyclophosphamide and Prednisone (REP) In Patients With Lenalidomide-Refractory Multiple Myeloma (REPEAT-study), Blood 122(21).
- Abouyahya, I.; Alhan, C.; Westers, T.M.; Boekhorst, P.A. te; Kappers-Klunne, M.C.; Coenen, J.L.; Heyning, F.H.; Huls, G.A.; Wolf, J.T. de; Imholz, A.L.; Koene, H.R.; Veth, G.; Kruijf, E.J.F.M. de; Muus, P.; Planken, E.V.; Segeren, C.M.; Vasmel, W.L.; Velden, A.M. van der; Velders, G.A.; Koedam, J.; Ossenkoppele, G.J. & Loosdrecht, A.A. van de (2013), Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program, Leukemia & Lymphoma 54(4): 874-877.
- Stevens, W.B.C.; Krieken, J.H. van; Mus, R.D.M.; Arens, A.I.J.; Mattijssen, V.; Oosterveld, M.; Kruijf, E.J.F.M. de; Vries, F. de; Koster, A.; Maazen, R. van der & Raemaekers, J. (2012), Centralised multidisciplinary re-evaluation of diagnostic procedures in patients with newly diagnosed Hodgkin lymphoma, Annals of Oncology 23(10): 2676-2681.
- Kruijf, E.J.F.M. de; Hagoort, H.; Velders, G.A.; Fibbe, W.E. & Pel, M. van (2010), Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration, Haematologica 95(7): 1061-1067.
- de Kruijf EJFM, van Pel M, Hagoort H, Kruysdijk D, Molineux G, Willemze R & Fibbe WE (2007), Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF, Human Immunology 68(5).
- Velders GA, Pruijt JFM, Verzaal P, van Os R, van Kooyk Y, Figdor CG, de Kruijf EJFM, Willemze R & Fibbe WE (2002), Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1, Blood 100(1).
- Pruijt JFM, Verzaal P, van Os R, de Kruijf EJFM, van Schie MLJ, Mantovani A, Vecchi A, Lindley IJD, Willemze R, Starckx S, Opdenakker G & Fibbe WE (2002), Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice, Proceedings of the National Academy of Sciences 99(9).
- de Kruijf EJFM, van Rijn ABB, Koelma IA, Kuijpers TJA & Van 't Wout JW (2000), Tuberculous aortitis with an aortoduodenal fistula presenting as recurrent gastrointestinal bleeding, Clinical Infectious Diseases 31(3).